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Abstract: Objectives: The mechanism behind spinal metabolites and myocardial ischemia-reperfusion (IR) injury 
is not well understood. Proton magnetic resonance spectroscopic analysis of spinal cord extracts provides a quick 
evaluation of the specific metabolic activity in rats with myocardial IR injury. We investigated the relationship be-
tween the IR-related variables and the changes in spinal metabolites. Methods: Proton magnetic resonance spec-
troscopy (1H-MRS) was used to assess the spinal metabolites of adult rats with and without myocardial IR injury (n 
= 6 per group). Myocardial IR injury was reproduced using intermittent occlusion of the left anterior descending 
coronary artery. We studied the relationship between the metabolite ratio measurement and IR-related variables. 
All rats underwent 1H-MRS, with the ratio of interest placed in different spinal cord segments to measure levels of 
twelve metabolites including N-acetylaspartate (NAA), taurine (Tau), glutamate (Glu), gamma amino acid butyric acid 
(GABA), creatine (Cr), and myoinositol (MI), etc. Results: Rats with myocardial IR injury had higher concentration of 
Tau in the upper thoracic spinal cord (P < 0.05), and lower concentration of Gly and Glu in the cervical segment of 
the spinal cord (P < 0.05), when compared to the Control group. The ratios of glutamate/taurine (Glu/Tau), Glu/
(GABA + Tau) and Glu/Total were significantly different between the IR group and the Control group in the upper 
thoracic spinal cord (P < 0.05). So were the ratios of Glu/(GABA + Tau) in the cervical segment (P < 0.05), and Glu/
Tau and Glu/(GABA + Tau) in the lower thoracic spinal cord (P < 0.05). Conclusions: These findings suggest that 
myocardial IR injury may be related to spinal biochemical alterations. It is speculated that these observed changes 
in the levels of spinal metabolites may be involved in the pathogenesis and regulation of myocardial IR injury.
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Introduction
Cardiac ischemia reperfusion injury is a ma- 
jor risk factor for deaths in patients with cardio-
vascular disease [1-3]. A heart-spinal cord 
interaction has been described in cardiac is- 
chemia [4] and related angina pectoris [5], 
but the mechanisms involved are unknown. 
Emerging research indicates that spinal cord 
stimulation (SCS) significantly alters the ex- 
pression level of nociceptive transmitter in the 
spinal cord during cardiac ischemia resulting 
in coronary artery occlusion in rat models [6- 
9]. There is emerging evidence that peripher- 
al nociceptive stimulation modulates spinal 
metabolism and cell growth in the spinal cord 
[10-13], and that spinal cellular adaptation 
to cardiac ischemic stress requires the co- 
ordination of cellular metabolic changes to 
maintain energy homeostasis [14, 15]. How- 
ever, the associations between amino acid 
levels in the spinal cord and myocardial isch-
emia-reperfusion (IR) injury remain relatively 
unknown.
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Only with a good understanding of the heart-
spinal cord crosstalk can we develop optimal 
treatment regimen for patients with cardiac 
ischemia. Regrettably, the metabolic mecha-
nism of the heart-spinal cord crosstalk remains 
unclear. Spinal cord neural-decoding that fo- 
cuses on capturing chemical metabolic profiles 
from spinal activities faces great challenges. In 
recent years, spinal cord neural decoding with 
magnetic resonance imaging signals has re- 
sulted in numerous studies being conducted. 
Complex spinal cord activity with limited data 
instances make it necessary to analyze the 
correlations between chemical metabolic sig-
nals and nociceptive stimuli. We previously 
demonstrated specific patterns of metabolite 
changes in spinal cords after the intradermal 
microinjection of two different pruritogens (α- 
Me-5-HT and histamine) and one algogenic 
compound (capsaicin) using proton nuclear ma- 
gnetic resonance spectroscopy (1H-MRS) [16]. 
This work contributed knowledge about the 
working mechanism of the spinal cord neural 
decoding, and established the effective con-
nectivity from peripheral nociceptive stimula-
tion to chemical metabolic profiles in the spinal 
cord. 
In the current study, we adopted a similar meth-
od of using 1H-MRS to investigate the altera-
tions of amino acid levels and metabolite ratio 
in rats’ spinal cord with myocardial IR injury 
reproduced using intermittent occlusion of the 
left anterior descending coronary artery.
dard controlled environment (22 ± 1°C, 40- 
70% humidity, 12-h light/dark cycles).
Myocardial IR injury model in rats
Rats were divided randomly into two groups. 
For Group 1, the Control group (n = 6), rats 
underwent all surgical procedures except for 
left anterior descending coronary arterial 
(LAD) clamping. For Group 2, the IR group (n = 
6), rats were exposed to the LAD clamp proce-
dure. The myocardial IR was performed as 
described previously [17-21]. Briefly, the rats 
were anesthetized with 50 mg/kg ketamine 
and 7.5 mg/kg xylazine i.p. using a lamp to 
regulate body temperature (37 ± 1°C) throu- 
gh a heating pad. Then tracheal intubation 
was set up and the lungs were mechanically 
ventilated. A left thoracic incision was per-
formed to expose the heart in the two gro- 
ups, and LAD coronary artery was clamped to 
form a reversible trap for 30 min and induce 
ischemia. Ischemia was confirmed by the color 
of the heart. For reperfusion, the clamp was 
removed, and the heart was monitored for co- 
lor change to confirm renewed blood flow be- 
fore suturing the incision. After reperfusion for 
2 h, the myocardial ischemic tissues were cut 
for histological and biochemical analyses 
whereas those from the spinal cord were col-
lected for 1H-MRS detection. The myocardi- 
al ischemic regions were prepared for Hema- 
toxylin-Eosin (HE) and lower sections of the 
heart were incubated with 1% 2,3,5-Triphenyl 
Figure 1. The normalized 1H-NMR spectra of the Thoracic spinal cord sam-
ples (T1-T6) in control and IR groups. Note: 1, ethanol; 2, lactate; 3, alanine; 
4, gamma amino acid butyric acid (GABA) + acetate; 5, N-aceytl aspartate 
(NAA); 6, glutamate; 7, glutamate + glutamine; 8, GABA; 9, glutamine; 10, 
asparate; 11, creatine; 12, choline; 13, taurine + myo-institol; 14, taurine; 
15, myo-institol; 16, glycine; 17, ethanol + myo-institol; 18, alanine + gluta-
mine + glutamate.
Material and methods
Animals
All experiments were perfor- 
med in accordance with the 
guidelines of the Experimen- 
tal Animal Laboratory and ex- 
perimental protocols (TJ-A20- 
150804) approved by the 
Animal Care and Use Com- 
mittee of Tongji Medical Col- 
lege, Huazhong University of 
Science and Technology. We 
used adult male SD rats 
(weighing 250-300 g) for our 
study. All animals were pro-
vided regular rat chow and 
water ad libitum, and were 
separately housed in a stan-
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Figure 2. Evaluation of the myocardial I/R model. A. Representative photo-
graphs in hearts subjected to I/R injury. After incubated with 2,3,5-Triphenyl 
Tetrazolium Chloride (TTC), the pale part of the slice heart tissue represents 
the infarct area. B. Serum cTnI concentrations in rats with control or I/R inju-
ry. Values are means ± SEM, n = 4 rats per group. Mann-Whitney test. ***P 
< 0.001 vs. control group. C. Representative photographs of HE staining of 
heart sections. The left panel shows the Control group and the right panel 
shows the IR group. Scale bar = 50 μm.
Tetrazolium Chloride (TTC) for 
10 min at 37°C. In addition, 
blood samples were obtained 
from the abdominal aorta to 
assess heart function.
Spinal cord sample for 
1H-MRS study and 1H-MRS 
data processing
Protocols for spinal cord tis-
sue extraction and 1H-MRS 
spectrum acquirement were 
the same as those described 
in our previous study [16].
For NMR spectral data pro-
cessing, the commercial soft-
ware TOPSPIN and NMRSpec 
were used [22-24], and a 
home-made MATLAB code. All 
the spectra were manually 
phased and the baseline cor-
rected in Topspin. The peak 
alignment and integration we- 
re completed in NMRSpec. 
The 18 related peak areas 
were calculated separately (Fi- 
gure 1).
Statistical analysis
Statistical data are shown as 
the mean ± standard error of 
the mean (SEM). Analysis was 
performed using GraphPad 
Prism 6.0. Comparisons be- 
tween the two groups were 
Figure 3. The concentration of 
identified metabolites in differ-
ent parts of the spinal cord in 
control and ischemia reperfusion 
(IR) groups. A1, A2. The cervical 
segment of the rat spinal cord; 
B1, B2. The upper thoracic spinal 
cord (T1-T6); C1, C2. The lower 
thoracic spinal cord (T7-T12). 
Data is presented as means ± 
SEM. Mann-Whitney test. *P < 
0.05. Note: Gly, glycine; Tau, tau-
rine; Cho, choline; Asp, asparate; 
Gln, glutamine; Glu, glutamate; 
GABA, gamma amino acid butyric 
acid; NAA, N-aceytl aspartate; 
Ala, alanine; Lac, lactate; Myo, 
myo-institol; Cre, creatine.
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performed using the Mann-Whitney test. The P 
values of less than 0.05 were considered sta-
tistically significant. 
Results
Evaluation of myocardial IR injury model
In this study, we used the histological and 
biochemical results to confirm the myocardial 
IR injury model. Representative images of TTC 
stained cross-sections of the heart are shown 
in Figure 2A. Serum cardiac troponin cTnI in 
the IR group was significantly increased com-
pared to the Control group (Figure 2B). The 
results from HE staining show that the cardiac 
structural disorders were observed in the IR 
group, whereas myocardial cells in the control 
group were complete and arranged in order 
(Figure 2C). 
Metabolic concentration and metabolic ratios 
in spinal cord extracts
In order to precisely assess the spinal changes 
after myocardial IR injury, absolute concen- 
trations of all the related metabolites were cal-
culated and compared (Tables S1-S3 and 
Figure 3). The average difference in normaliz- 
ed 1H-NMR spectra of selected metabolites 
between control and IR groups are displayed in 
Figure 4.
Rats with myocardial IR injury had higher con-
centration of taurine (Tau) in the upper region 
of the thoracic spinal cord (P < 0.05) (Figure 
3B; Tables 1 and S1-S3), and lower concen- 
tration of glycine (Gly) and glutamate (Glu) in 
the cervical segment (P < 0.05) (Figure 3A; 
Tables 1 and S1-S3), compared to the Control 
group. 
Figure 4. The average difference in normalized 1H-NMR spectra of selected metabolites in control and ischemia 
reperfusion (IR) groups. A1-A3. The average spectra of glycine; B1-B3. The average spectra of taurine; C1-C3. The 
average spectra of glutamate. A1-C1. Represent the Cervical spinal cord; A2-C2. Represent the upper Thoracic 
spinal cord (T1-T6); A3-C3. Represent the lower Thoracic spinal cord (T7-T12). Note: the green line represents the 
average level and the green color surround means the SEM of the control group; the blue line represents the aver-
age level and the blue color surround means the SEM of the control group. The p value was calculated from the 
concentration of certain metabolites.
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Table 2. Comparisons of the spinal levels of the metabolic 
ratios of different groups
Spinal Segment Metabolite Ratio Control IR p
C1-8 Glu/Tau 1.70 ± 0.12 1.30 ± 0.13 0.052
Glu/Total 0.49 ± 0.02 0.42 ± 0.02 0.045
Glu/(GABA+Tau) 0.94 ± 0.04 0.78 ± 0.06 0.058
T1-6 Glu/Tau 1.37 ± 0.08 1.17 ± 0.04 0.043
Glu/Total 0.45 ± 0.01 0.42 ± 0.01 0.028
Glu/(GABA+Tau) 0.78 ± 0.03 0.71 ± 0.01 0.048
T7-12 Glu/Tau 1.56 ± 0.09 1.23 ± 0.11 0.046
Glu/Total 0.48 ± 0.02 0.43 ± 0.02 0.104
Glu/(GABA+Tau) 0.85 ± 0.03 0.72 ± 0.04 0.041
Note: C1-C8, the cervical segment of the rat spinal cord; T1-T6, the upper tho-
racic spinal cord; T7-T12, the lower thoracic spinal cord. Data was presented 
as means ± SEM. Mann-Whitney test. P < 0.05 was marked as bold.
Table 1. The concentration of selected metabolites in different 
segments of the spinal cord
Spinal Segment Metabolite Control (μmol/g) IR (μmol/g) P
C1-8 Glycine 4.26 ± 0.08 3.98 ± 0.08 0.033
Taurine 2.65 ± 0.14 3.31 ± 0.37 0.127
Glutamate 4.33 ± 0.11 3.88 ± 0.17 0.042
T1-6 Glycine 3.56 ± 0.17 3.86 ± 0.12 0.181
Taurine 2.84 ± 0.16 3.53 ± 0.16 0.011
Glutamate 3.81 ± 0.20 4.07 ± 0.10 0.303
T7-12 Glycine 3.72 ± 0.56 3.50 ± 0.15 0.196
Taurine 2.65 ± 0.37 3.29 ± 0.17 0.325
Glutamate 4.09 ± 0.59 3.87 ± 0.21 0.204
Note: C1-C8, the cervical segment of the rat spinal cord; T1-T6, the upper tho-
racic spinal cord; T7-T12, the lower thoracic spinal cord. Data was presented 
as means ± SEM. Mann-Whitney test. P < 0.05 was marked as bold.
Tables 2 and S1, S2, S3, S4, S5, S6 illustrate 
the comparisons of the mean levels of metabo-
lite ratios between the two groups, and that 
rats in the IR group had lower levels of gluta-
mate/taurine (Glu/Tau), Glu/(GABA + Tau) and 
Glu/Total than that of the Control group. Of 
note, the ratios of Glu/Tau, Glu/(GABA + Tau) 
and Glu/Total were significantly different be- 
tween the groups in the upper thoracic spinal 
cord (P < 0.05) (Figure 5B; Table 2). So were 
the ratios of Glu/(GABA + Tau) in the cervical 
segment (P < 0.05) (Figure 5A; Table 2), and 
Glu/Tau and Glu/(GABA + Tau) in the lower tho-
racic spinal cord (P < 0.05) (Figure 5C; Table 2).
Discussion
The current study investigated the metabolic 
concentration and ratios in spinal cord extra- 
cts of rats with and without LAD 
ligation as assessed by 1H-MRS, 
and compared the association of 
these variables in different spi-
nal cord segments. The principal 
findings are as following: (1) LAD 
ligation resulted in myocardial IR 
injury; (2) The 1H-MRS-measured 
Tau concentration in the upper 
thoracic spinal cord and exhibit-
ed a dramatic increase whereas 
Gly and Glu concentration of the 
cervical segment showed a sig-
nificant decrease in the IR group; 
(3) Glu/(GABA + Tau) and Glu/
Tau were significantly different 
between the groups in the upper 
thoracic spinal cord, indicating 
that in the spinal cord Glu/(GABA 
+ Tau) and Glu/Tau are the sur-
rogate markers of myocardial IR 
injury.
There is now substantial evi-
dence that afferent feedback 
from the heart to the higher cen-
tres may affect efferent input to 
the heart and modulate cardiac 
physiology [25]. The rapid devel-
opment of 1H-MRS could detect 
and quantify hundreds of pro-
teins and metabolites [26, 27], 
which are located downstream 
of the entire biology system, 
and represent the direct perfor-
mance of the life system and final feedback of 
the overall biological processes. We found that 
the 1H-MRS-measurement of Tau concentra-
tion in the T1-T6 spinal cord exhibited a dramat-
ic increase in the IR group. As an inhibitory 
amino acid, Tau (2-aminoethanesulfonic acid) 
plays an important role in the maintenance of 
calcium homeostasis, membrane stabilization, 
antioxidation, and antiinflammatory action [28-
30]. Smullin reported that Tau release in res- 
ponse to chemical tests of nociception may 
contribute to the effective endogenous antino-
ciceptive effect [28]. Some studies confirmed 
that Tau had protective effects against early 
renal injury in several animal models with po- 
tent endogenous antioxidative properties [31-
33]. Cavdar investigated the effects of Tau 
and the possible role of p38 MAPK signaling 
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Figure 5. The metabolite ratios of different parts of 
the spinal cord between the Control group and theIR 
group. A. The Cervical segment of the spinal cord; B. 
The upper Thoracic spinal cord (T1-T6); C. The lower 
Thoracic spinal cord (T7-T12). Data was presented as 
means ± SEM. Mann-Whitney test. *P < 0.05. Note: 
Gly, glycine; Tau, taurine; Cho, choline; Asp, asparate; 
Gln, glutamine; Glu, glutamate; GABA, gamma amino 
acid butyric acid; NAA, N-aceytl aspartate; Ala, ala-
nine; Lac, lactate; Myo, myoinstitol; Cre, creatine.
on the regulation of MMP-2 and MMP-9 in a 
renal IR injury model in rats, and found that Tau 
administration may prove to be a strategy for 
attenuating renal IR injury [31]. Thus, these 
data could further explain the mechanism 
behind the significantly higher Tau in the spinal 
cord related to myocardial IR injury. Besides, 
Taurine is closely related to neural cell damage 
[34]. We noticed that absolute Taurine con- 
centration in the spinal tissue was much lower 
than normal animals. However, the experimen-
tal animals undergoing the procedures were 
much different from normal animals. So we 
could not exclude that the effects of the expe- 
rimental operation itself will distinguish the 
results from naive animals, which needs fur-
ther study.
Despite the existence of published mathemati-
cal techniques for 1H-MRS-measuring absolute 
quantification, relative metabolite ratios are 
valid and useful. Region specific changes in 
relative metabolite ratios, such as NAA/Cr, 
Cho/Cr, and NAA/Cho have been found in a 
number of different neurological conditions. 
Widerström-Noga et al first reported a method 
to detect the 1H-MRS in the anterior cingulate 
cortex and they found that glutamate-gluta-
mine/myoinositol (Glx/Ins) ratio might be a 
useful biomarker for severe SCI-related neuro-
pathic pain with significant psychosocial im- 
pact [35]. By using a similar method, Wang et al 
reported low levels of NAA/Cr and Cho/Cr in the 
hypothalamus of patients with episodic cluster 
headaches, suggesting that cluster headaches 
might be related to both neuronal dysfunction 
and changes in membrane lipids in the hypo-
thalamus [36]. 1H-MRS metabolite ratios mea-
sured in this study showed that Glu/(GABA + 
Tau) and Glu/Tau were significantly different 
between the IR group and Control group in the 
upper thoracic spinal cord, suggesting meta-
bolic changes of excitatory and inhibitory amino 
acids in the spinal cord.
In conclusion, this study demonstrated that 
myocardial ischemia-reperfusion injury affect-
ed the tissue levels of amino acids and their 
ratios in the investigated spinal cord regions, 
suggesting that alterations in the spinal metab-
olisms of amino acids associated with myocar-
dial ischemia-reperfusion injury are involved in 
the effects of central regulation.
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Spinal metabolites after myocardial injury
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Table S1. The concentration of selected metabo-
lites in different segments of C1-C8
Metabolite Control (μmol/g) IR (μmol/g) P
Cretine 18.40 ± 0.30 17.84 ± 0.84 0.561
Glycine 4.26 ± 0.08 3.98 ± 0.08 0.033
Myo-Ins 11.54 ± 0.18 10.89 ± 0.29 0.084
Taurine 2.65 ± 0.14 3.31 ± 0.37 0.127
Choline 0.19 ± 0.01 0.18 ± 0.02 0.641
Asparate 0.79 ± 0.03 0.66 ± 0.05 0.055
Glutamine 5.88 ± 0.11 5.52 ± 0.19 0.149
Glutamate 4.33 ± 0.11 3.88 ± 0.17 0.042
GABA 1.99 ± 0.04 1.84 ± 0.08 0.124
NAA 3.92 ± 0.11 3.54 ± 0.19 0.115
Alanine 0.82 ± 0.04 0.80 ± 0.06 0.748
Lactate 10.25 ± 0.51 8.89 ± 0.35 0.054
Table S2. The concentration of selected metabo-
lites in different segments of T1-6
Metabolite Control (μmol/g) IR (μmol/g) P
Cretine 11.50 ± 0.92 13.78 ± 1.15 0.161
Glycine 3.56 ± 0.17 3.86 ± 0.12 0.181
Myo-Ins 11.28 ± 0.48 12.20 ± 0.35 0.157
Taurine 2.84 ± 0.16 3.53 ± 0.16 0.011
Choline 0.26 ± 0.01 0.27 ± 0.01 0.487
Asparate 0.64 ± 0.03 0.69 ± 0.02 0.166
Glutamine 5.59 ± 0.25 6.05 ± 0.14 0.138
Glutamate 3.81 ± 0.20 4.07 ± 0.10 0.303
GABA 2.04 ± 0.10 2.23 ± 0.06 0.152
NAA 3.30 ± 0.15 3.58 ± 0.09 0.151
Alanine 0.90 ± 0.06 0.93 ± 0.04 0.617
Lactate 8.68 ± 0.51 8.79 ± 0.30 0.863
Table S3. The concentration of selected metabo-
lites in different segments of T7-10
Metabolite Control (μmol/g) IR (μmol/g) P
Cretine 12.18 ± 1.93 13.44 ± 1.13 0.965
Glycine 3.72 ± 0.56 3.50 ± 0.15 0.196
Myo-Ins 12.06 ± 1.77 11.66 ± 0.43 0.249
Taurine 2.65 ± 0.37 3.29 ± 0.17 0.325
Choline 0.28 ± 0.04 0.26 ± 0.01 0.117
Asparate 0.70 ± 0.10 0.66 ± 0.04 0.200
Glutamine 5.93 ± 0.87 5.71 ± 0.24 0.244
Glutamate 4.09 ± 0.59 3.87 ± 0.21 0.203
GABA 2.18 ± 0.32 2.13 ± 0.10 0.303
NAA 3.58 ± 0.52 3.49 ± 0.17 0.285
Alanine 0.94 ± 0.12 0.90 ± 0.02 0.104
Lactate 9.11 ± 1.19 8.39 ± 0.37 0.063
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Table S4. Comparisons of the levels of the metabolic 
ratios of different groups in C1-8
Metabolic ratio Control IR P
Glu/GABA 2.178 ± 0.042 2.119 ± 0.038 0.330
Glu/Gly 1.019 ± 0.029 0.971 ± 0.031 0.295
Glu/Tau 1.696 ± 0.123 1.300 ± 0.133 0.052
Glu/(GABA + Gly) 0.694 ± 0.017 0.664 ± 0.016 0.250
Glu/(GABA + Tau) 0.944 ± 0.042 0.784 ± 0.057 0.045
Glu/(Gly + Tau) 0.631 ± 0.024 0.543 ± 0.034 0.063
Glu/Total 0.489 ± 0.016 0.429 ± 0.023 0.058
Table S5. Comparisons of the levels of the metabolic 
ratios of different groups in T1-6
Metabolic ratio Control IR P
Glu/GABA 1.861 ± 0.031 1.830 ± 0.042 0.575
Glu/Gly 1.068 ± 0.023 1.056 ± 0.020 0.717
Glu/Tau 1.368 ± 0.077 1.167 ± 0.042 0.043
Glu/(GABA + Gly) 0.678 ± 0.013 0.669 ± 0.011 0.605
Glu/(GABA + Tau) 0.783 ± 0.027 0.708 ± 0.014 0.028
Glu/(Gly + Tau) 0.596 ± 0.019 0.551 ± 0.009 0.055
Glu/Total 0.451 ± 0.012 0.423 ± 0.005 0.048
Table S6. Comparisons of the levels of the metabolic 
ratios of different groups in T7-10
Metabolic ratio Control IR P
Glu/GABA 1.882 ± 0.035 1.822 ± 0.041 0.324
Glu/Gly 1.108 ± 0.028 1.109 ± 0.033 0.984
Glu/Tau 1.564 ± 0.086 1.229 ± 0.114 0.046
Glu/(GABA + Gly) 0.697 ± 0.015 0.689 ± 0.018 0.752
Glu/(GABA + Tau) 0.850 ± 0.032 0.720 ± 0.043 0.041
Glu/(Gly + Tau) 0.645 ± 0.023 0.574 ± 0.033 0.119
Glu/Total 0.480 ± 0.015 0.434 ± 0.020 0.104
